deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT04475107

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

A Multi-center, Randomized, Double-blind, Parallel, Placebo-Controlled, Phase Ⅱ Clinical Trial to Evaluate Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Sponsor: Shin Poong Pharmaceutical Co. Ltd.

Conditions COVID-19
Interventions Placebo Pyronaridine-Artesunate
Updated 9 times since 2020 Last updated: May 27, 2021 Started: Jul 9, 2020 Primary completion: Mar 25, 2021 Completion: Apr 15, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on COVID-19, this trial is completed. The trial is conducted by Shin Poong Pharmaceutical Co. Ltd. and has accumulated 9 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshotRecruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotRecruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotRecruiting~Apr 2021 – ~May 2021 · 30 days · monthly snapshotRecruiting~May 2021 – ~Sep 2021 · 4 months · monthly snapshotCompleted~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Sep 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. May 2021 — Sep 2021 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

▶ Show 4 earlier versions

  1. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE2

  2. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE2

  3. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  4. Aug 2020 — Nov 2020 [monthly]

    Recruiting PHASE2

    First recorded

Jul 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shin Poong Pharmaceutical Co. Ltd.
Data source: Shin Poong Pharmaceutical Co. Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations